Showing BioInteractions for Magnesium gluconate (DB13749)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Magnesium gluconate is a Hexokinase substrate | ||
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Magnesium gluconate is a Creatine kinase B-type substrate | ||
| 1 | Creatine kinase B-type ligands | Creatine, Phosphocreatine |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Magnesium gluconate is a Creatine kinase B-type inducer | ||
| 1 | Creatine kinase B-type ligands | Creatine, Phosphocreatine |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Magnesium gluconate is a Tyrosine-protein kinase ABL1 substrate | ||
| 1 | Tyrosine-protein kinase ABL1 inhibitors | ATP, Bosutinib, Brigatinib, Fostamatinib, Imatinib, Nilotinib, Ponatinib, Regorafenib |
| 2 | Tyrosine-protein kinase ABL1 antagonists | Radotinib |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Magnesium gluconate is a Tyrosine-protein kinase ABL1 inducer | ||
| 1 | Tyrosine-protein kinase ABL1 inhibitors | ATP, Bosutinib, Brigatinib, Fostamatinib, Imatinib, Nilotinib, Ponatinib, Regorafenib |
| 2 | Tyrosine-protein kinase ABL1 antagonists | Radotinib |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Magnesium gluconate is a ATP synthase subunit delta, mitochondrial substrate | ||
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Magnesium gluconate is a Adenylate cyclase type 1 substrate | ||
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Magnesium gluconate is a Guanylate cyclase soluble subunit alpha-2 substrate | ||
| 1 | Guanylate cyclase soluble subunit alpha-2 inducers | Molsidomine, Nitric Oxide, Pentaerythritol tetranitrate |
| 2 | Guanylate cyclase soluble subunit alpha-2 activators | Isosorbide mononitrate |
| 3 | Guanylate cyclase soluble subunit alpha-2 agonists | Molsidomine, Plecanatide, Riociguat |
| 4 | Guanylate cyclase soluble subunit alpha-2 stimulators | Riociguat |
| 5 | Guanylate cyclase soluble subunit alpha-2 inhibitors | Methylene blue |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Magnesium gluconate is a 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 inducer | ||
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Magnesium gluconate is a Phosphoribosylpyrophosphate synthetase inducer | ||
| 1 | Phosphoribosylpyrophosphate synthetase ligands | Artenimol |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Magnesium gluconate is a Sodium/potassium-transporting ATPase subunit alpha-1 inducer | ||
| 1 | Sodium/potassium-transporting ATPase subunit alpha-1 inhibitors | Acetyldigitoxin, Bepridil, Bretylium, Deslanoside, Digitoxin, Digoxin, Etacrynic acid, Ouabain, Trichlormethiazide |
| 2 | Sodium/potassium-transporting ATPase subunit alpha-1 inducers | Hydroflumethiazide |
| 3 | Sodium/potassium-transporting ATPase subunit alpha-1 binders | Almitrine, Aluminium, Ciclopirox |
| 4 | Sodium/potassium-transporting ATPase subunit alpha-1 substrates | Potassium, Potassium gluconate, Rubidium Rb-82 |